Preclinical development support
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSN272201100021I
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 37 $116,372,194 obligated
Award facts
- Opportunity
-
- NIAID Preclinical Development Support Award Notice · Posted May 18, 2016
- Preclinical Development Support Award Notice · Posted Aug 13, 2010
- Combined order value
-
- $116,372,194 Current, with exercised options
- $123,229,346 Potential, with all options
- Last date to order 89% complete
- IDV ceiling 93% used
- $124,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support services, including biologics manufacturing, testing, storage, shipping, and quality assurance for vaccine, therapeutic, and diagnostic development programs.
Under this IDC, multiple task orders have been issued to ABL, a foreign-owned for-profit manufacturer, with a total potential value over $35 million. The task orders cover a range of preclinical support activities such as cGMP production of vaccine candidates, monoclonal antibodies, and HIV proteins, as well as stability testing, assay development, toxicology studies, and regulatory documentation. The place of performance for all task orders is Potomac, MD. The contract is not set aside and utilizes a cost-plus-fixed-fee pricing structure.
Task orders
Show all 37
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN272201100021I?
HHSN272201100021I was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 29, 2011.
How much is contract HHSN272201100021I worth?
Orders under HHSN272201100021I have obligated $116,372,194. Their combined potential value, with all options, is $123,229,346. HHSN272201100021I's own ceiling is $124,500,000.
How many orders have been placed under contract HHSN272201100021I?
37 orders have been placed under HHSN272201100021I, the latest on August 25, 2017.
Who can order from contract HHSN272201100021I?
HHSN272201100021I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSN272201100021I competed?
The extent of competition for HHSN272201100021I was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV